Medical treatment of dystonia

Clinical Neurology

Volumn 41, Issue 12, 2001, Pages 1181-1182

  Kachi, Teruhiko ^a  

^a CHUBU NATIONAL HOSPITAL   (Japan)

Author keywords

Anticholinergic drugs; Diazepam; Dystonia; Spasmodic torticollis

Indexed keywords

BOTULINUM TOXIN; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONAZEPAM; DIAZEPAM; DOPAMINE RECEPTOR BLOCKING AGENT; LEVODOPA;

CONFERENCE PAPER; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG MEGADOSE; DYSTONIA; HUMAN; MYOCLONUS; PROGNOSIS; SYMPTOMATOLOGY; TREMOR;

CHOLINERGIC ANTAGONISTS; CLONAZEPAM; DIAZEPAM; DOPAMINE ANTAGONISTS; DYSTONIA; HUMANS; LEVODOPA; TORTICOLLIS; TRIHEXYPHENIDYL;

EID: 0035760332     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (10)

1. Ad Hoc Committee Established by the Research Group on Extrapyramidal Disorders of the World Federation of Neurology: Classification of extrapyramidal disordere, proposal for an International Classification and Glossary of Terms. J Neurol Sci 51: 311-327, 1981
2. Yanagisawa N, Goto A, Narabayashi H: Familial dystonia musculorum deformans and tremor. J Neurol Sci 16: 125-136, 1972
3. Obeso J, Rothwell JC, Lang AE, et al: Myoclonic dystonia. Neurology, 33: 825-830, 1983
4. Stejskal L: Counterpressure in torticollis. J Neurol Sci 48: 9-19, 1980
5. Fahn S: High dosage anticholinergic therapy in dystonia. Neurology 33: 1255-1261, 1983
6. Marsden CD, Marion M-H, Quinn N: The treatment of severe dystonia in children and adults. J Neurol Neurosurg Psychiatry 47: 1166-1173, 1984
7. Shaw KW, Hunter KR, Sstern GM: Medical treatment of spasmodic torticollis. Lancet 1982; 1: 1399